How to Buy Biolife Solutions Stock
Biolife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally.
Biolife Solutions stock last closed at $22.03, down 5.45% from the previous day, and has increased 7.25% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.58 percentage points. Biolife Solutions stock is currently +17.81% from its 52-week low of $18.70, and -25.44% from its 52-week high of $29.55.
As of Jun 13, 2025, there are 47.56M shares of BLFS outstanding. The market capitalization of BLFS is $1.05B. In the past 24 hours, 820,000 BLFS shares were traded.
How to Buy Biolife Solutions Stock
Wondering how to invest in Biolife Solutions stock? Here's how.
- Figure out where to buy Biolife Solutions stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Biolife Solutions stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Select your payment method and add your information.
- Research Biolife Solutions stock: The Biolife Solutions ticker symbol is BLFS. Is Biolife Solutions stock a good investment? Should you buy shares of BLFS? How do BLFS's underlying business fundamentals look? Do top analysts think Biolife Solutions is a good buy? Why has BLFS's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if BLFS is a good stock to buy).
- Make your BLFS purchase: Decide if you will purchase BLFS shares at the current market price or use a limit order to buy BLFS stock at a specific price.
- Get key alerts regarding your investment in BLFS: Create a watchlist to important updates regarding your new investment in Biolife Solutions shares.
Step 1: Figure out where to buy Biolife Solutions stock
You will need a brokerage account to access the NASDAQ market and buy BLFS stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal details so you are able to invest in BLFS today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on mobile trading apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details depositing money into your new investment account.
Step 4: Research Biolife Solutions stock
After you have identified the best place to buy Biolife Solutions stock, it's important to evaluate their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Biolife Solutions Numbers
Biolife Solutions Overview
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on BLFS's stock page.
Is BLFS stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge BLFS's true value.
Using relative valuations metrics:
- BLFS may be undervalued based on its P/B ratio of 2.97x, relative to Medical Instruments & Supplies industry P/B ratio of 3.59x
You can do additional valuation analysis on BLFS's stock here.
A quick look at BLFS Financials
Positive Health Checks:
- BLFS profit margin has gone up from -99.1% to -13.1% in the past year.
- There are more short-term assets than long-term liabilities on the BLFS balance sheet.
- Total BLFS debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the BLFS balance sheet.
- BLFS's operating cash flow of $14.63M allows it to safely service it's debt of $26.95M.
- BLFS has a low debt to equity ratio of 0.12.
Negative Health Checks:
- BLFS earnings of -$10.69M is not enough to cover its interest payments.
Is it a good time to buy BLFS stock, according to Wall Street analysts?
Out of 3 Wall Street analysts who give ratings on BLFS, the consensus analyst rating on Biolife Solutions is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Biolife Solutions stock forecast page.
BLFS Momentum
BLFS Earnings
Last year, BLFS revenue was $79.42M. During the past 5 year, BLFS's revenue has gone up by 18.66% per year. This was faster than the Medical Instruments & Supplies industry average of 10.32%.
Dig into BLFS's earnings and revenue performance here.
Who is buying/selling BLFS?
Over the last year, insiders at BLFS have sold more shares than they have bought.
Sarah Aebersold, Chief Human Resources Officer of BLFS, was the latest BLFS insider to sell. They sold $5,569.50 worth of BLFS shares on Jun 10, 2025.
Get more info about who owns BLFS stock here.
Does BLFS stock generate passive income?
No, Biolife Solutions doesn't provide an income stream by paying out dividends.
BLFS Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your BLFS purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Press the Open Trade button and your broker will place your order.
If you need more help with buying stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your investment in BLFS
Now that you own some BLFS stock, you'll want to keep up with your new shares.
Start a watchlist to track the most important metrics related to your BLFS stock.
BLFS Feed
How to Buy Stock in Biolife Solutions
To reiterate, here are the 6 steps for buying Biolife Solutions stock:
- Figure out where to buy Biolife Solutions stock
- Create your brokerage account
- Put funds into your brokerage account
- Research Biolife Solutions stock
- Make your BLFS purchase
- Get key alerts regarding your investment in BLFS
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep tabs on your investment in Biolife Solutions, add BLFS to your watchlist by clicking the button below.
Other Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.